This MR analysis provides the first confirmation that CD62L− Dendritic Cell Absolute Count is positively correlated with the development of prostate cancer, while FSC-A on plasmacytoid Dendritic Cell shows a negative correlation. The gene discussed is SELL; the disease is prostate cancer.